Organogenesis Holdings Inc.
Develops regenerative biomaterials for wound care, surgical, and sports medicine markets.
ORGO | NDAQ
Overview
Corporate Details
- ISIN(s):
- US68621F1021
- LEI:
- Country:
- United States of America
- Address:
- 85 DAN ROAD, 2021 CANTON
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacturing, and commercialization of solutions for the advanced wound care, surgical, and sports medicine markets. The company offers a portfolio of bioactive and acellular biomaterials products designed to empower healing. Its core activities encompass the entire product lifecycle, from research and development to sales and distribution of its regenerative tissue innovations.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Organogenesis Holdings Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Organogenesis Holdings Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Organogenesis Holdings Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
